FDA official logo
GSRS logo
PFDA official logo

HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN

  • UNII: J2D279PEM5
  • Preferred Substance Name: HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN

  • GARDASIL 9 COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN J2D279PEM5 DEFINITION TYPE
  • GARDASIL COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
  • GARDASIL-9 COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN J2D279PEM5 DEFINITION TYPE
  • HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE, RECOMBINANT INJECTION, SUSPENSION COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN
  • HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT INJECTION, SUSPENSION COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN
  • HUMAN PAPILLOMAVIRUS TYPE 18 CAPSID PROTEIN ANTIGEN, A
  • HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
  • HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE
  • HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN COMPONENT OF GARDASIL
  • HUMAN PAPILLOMAVIRUS TYPE 18 L1 PRTOEIN COMPONENT OF SILGARD
  • L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18
  • L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 VACCINE
  • RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
  • SILGARD COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.